查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132295

局部鎮痛藥市場規模、佔有率和趨勢分析報告：按藥物類別、疼痛類型、劑型、處方類型、分銷管道、地區和細分市場預測（2026-2033 年）

Topical Analgesics Market Size, Share & Trends Analysis Report By Drug Class (Non-Steroidal Anti-Inflammatory Drugs ), By Pain, By Dosage Form, By Prescription, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

局部止痛藥市場概覽

全球局部止痛藥市場預計到 2025 年將達到 119 億美元，從 2026 年的 125 億美元成長到 2033 年的 186 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 5.9%。

北美市場領先，到 2025 年將佔全球銷售額的 41.2%。市場成長的促進因素包括慢性肌肉骨骼疾病、骨關節炎、類風濕性關節炎和運動傷害的日益普遍，以及人口老化導致長期疼痛管理需求增加。

與口服鎮痛藥相比，局部鎮痛的全身副作用較少，因此消費者越來越傾向於選擇局部鎮​​痛方式，這促進了此類產品的廣泛應用。非處方藥的普及、經皮給藥技術的進步以及具有處方藥級療效的局部製劑的推出，進一步推動了市場發展。此外，消費者自我護理意識的提高、對非鴉片類止痛方法的需求成長，以及透過零售藥局、電商平台和醫院藥局等管道的廣泛銷售，也持續提升了產品的可近性。持續的產品創新，例如藥物滲透技術的改進和長效局部製劑的研發，也為市場成長做出了貢獻。

市場集中度和特徵

局部鎮痛藥產業正展現出中等至高度的創新水平，這主要得益於藥物遞送系統、製劑技術和更人性化劑型的進步。製造商們正在推出改良的經皮貼片、速效凝膠、噴霧、乳霜和滾珠製劑，以增強藥物滲透性並提供持久的鎮痛效果。研發重點還包括非鴉片類藥物療法、複方製劑以及局部貼片黏附技術的改進。各公司不斷擴展其處方藥和非處方藥產品系列，以應對肌肉骨骼疼痛、關節炎、神經病變疼痛和運動傷害。雖然許多活性成分，例如雙氯芬酸鈉、Lidocaine、辣椒素和薄荷醇，已經被廣泛應用，但製劑的改進和差異化的遞送技術仍在持續推動著整個市場的產品創新。

由於監管要求、配方專業知識和生產標準等因素，外用鎮痛藥行業的進入門檻適中。企業必須證明其產品品質、穩定性、生物利用度和安全性，才能獲得監管部門的批准，尤其是處方箋外用產品。開發有效的經皮給藥系統需要專門的研發能力和生產基礎設施。然而，由於成熟的活性成分和契約製造組織（CMO）的存在，開發學名藥藥和上市藥物的複雜性有所降低。大型製藥企業受益於其成熟的分銷網路、監管合規經驗和品牌知名度，而區域性製造商則繼續透過非專利藥和自有品牌產品進入市場。

監管機構在維護外用鎮痛藥的安全性、有效性和品質方面發揮著至關重要的作用。處方藥在核准前需要大量的臨床和生產文件，而上市藥物則必須符合適用的國家標準和監管要求。生產設施必須符合藥品生產品質管理規範 (GMP) 標準，生產商必須遵守標籤、藥物警戒和上市後監測要求。監管部門也負責控制產品功效標籤、活性成分濃度和生產一致性。雖然合規性可能會增加研發時間和成本，但它也是產品品質的保障，並能增強醫護人員和消費者的信心。

由於有許多替代性疼痛管理方法，局部止痛藥產業的特點是產品頻繁更替。患者通常會根據疼痛程度和臨床指徵，選擇口服非類固醇抗發炎藥 (NSAIDs)、對乙醯胺酚、鴉片類藥物、皮質類固醇注射、物理治療和輔助療法。非藥物療法，例如熱療、冷療、運動療法和復健服務，也與局部用藥競爭。在局部用藥領域，種類繁多的乳膏、凝膠、噴霧劑、貼片、軟膏和含有不同活性成分的抗刺激產品提供了更多選擇。學名藥的廣泛普及進一步加劇了處方藥和非處方藥 (OTC) 領域的競爭。

隨著製藥公司不斷加強在北美、歐洲、亞太、拉丁美洲以及中東和非洲的業務佈局，其地理擴張仍保持中等至較高水準。這一成長得益於人們對局部疼痛管理的認知度不斷提高、零售藥局網路不斷擴張、電子商務的普及以及新興經濟體醫療保健服務可近性的改善。各公司正透過區域夥伴關係、授權協議和拓展分銷管道，將已獲已通過核准的產品推向更多國家。肌肉骨骼疾病盛行率的上升、人口老化以及對自我止痛需求的不斷成長，持續為業務擴張提供動力。此外，本土生產商也正在透過推出經濟實惠的非專利局部鎮痛藥，擴大其在發展中國家醫療保健市場的供應。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 局部止痛藥市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析

第4章 局部止痛藥市場：依藥物類別進行業務分析

  • 按藥物類別分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按藥物類別分類，2021-2033 年
  • 非類固醇消炎劑（NSAIDs）
  • 局部麻醉劑
  • 抗促效劑
  • 辣椒素類止痛藥
  • 複方局部鎮痛劑

第5章 局部止痛藥市場：依疼痛類型分類的商業分析

  • 按疼痛類型分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按疼痛類型分類，2021-2033 年
  • 傷害性疼痛
  • 神經病變疼痛
  • 混合疼痛

第6章 局部鎮痛藥市場：以劑型分類的業務分析

  • 按劑型分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按劑型分類，2021-2033 年
  • 奶油
  • 凝膠
  • 軟膏
  • 修補
  • 噴
  • 其他

第7章 局部止痛藥市場：依處方類型分類的商業分析

  • 按劑型分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按劑型分類，2021-2033 年
  • 處方藥（Rx）

第8章 局部鎮痛藥市場：按分銷管道分類的業務分析

  • 按劑型分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按劑型分類，2021-2033 年
  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 超級市場和大賣場

第9章 局部止痛藥市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • Haleon plc
    • Hisamitsu Pharmaceutical Co., Inc.
    • Kenvue Inc.
    • Sanofi SA
    • Viatris Inc.
    • Teikoku Pharma USA, Inc.
    • Perrigo Company plc
    • Reckitt Benckiser Group plc.
    • Advantice Health, LLC.
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-934-3

Topical Analgesics Market Summary

The global topical analgesics market size was valued at USD 11.9 billion in 2025 and is projected to grow from USD 12.5 billion in 2026 to USD 18.6 billion by 2033, at a CAGR of 5.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 41.2% in 2025. Growth in the market is supported by the increasing prevalence of chronic musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, sports-related injuries, and an aging population requiring long-term pain management.

Rising preference for localized pain relief with redud systemic adverse effects compared to oral analgesics has contributed to broader product adoption. The expansion of OTC availability, improvements in transdermal drug delivery technologies, and the introduction of prescription-strength topical formulations have further strengthened market development. In addition, growing consumer awareness regarding self-care, increasing demand for non-opioid pain management options, and wider availability through retail pharmacies, e-commerce platforms, and hospital pharmacies continue to support product accessibility. Ongoing product innovation, including enhanced drug penetration technologies and long-acting topical formulations, is further contributing to market growth.

Market Concentration & Characteristics

The topical analgesics industry demonstrates a moderate-to-high degree of innovation driven by advancements in drug delivery systems, formulation technologies, and patient-friendly dosage forms. Manufacturers are introducing improved transdermal patches, fast-absorbing gels, sprays, creams, and roll-on formulations that enhance drug penetration and provide prolonged pain relief. Development activities are also focused on non-opioid therapies, combination formulations, and improved adhesive technologies for topical patches. Companies continue to expand both prescription and over-the-counter product portfolios to address musculoskeletal pain, arthritis, neuropathic pain, and sports injuries. While many active pharmaceutical ingredients such as diclofenac, lidocaine, capsaicin, and menthol are well established, formulation improvements and differentiated delivery technologies continue to support product innovation across the market.

Barriers to entry in the topical analgesics industry are moderate due to regulatory requirements, formulation expertise, and manufacturing standards. Companies must demonstrate product quality, stability, bioavailability, and safety before obtaining regulatory approval, particularly for prescription topical products. Development of effective transdermal delivery systems requires specialized research capabilities and manufacturing infrastructure. However, the availability of established active pharmaceutical ingredients and the presence of contract manufacturing organizations reduce development complexity for generic and over-the-counter products. Large pharmaceutical companies benefit from established distribution networks, regulatory experience, and brand recognition, while regional manufacturers continue to enter the market through generic formulations and private-label products.

Regulatory agencies play an important role in maintaining the safety, efficacy, and quality of topical analgesic products. Prescription formulations require extensive clinical and manufacturing documentation before approval, while over-the-counter products must comply with applicable monograph requirements or regulatory pathways in individual countries. Manufacturing facilities are required to meet Good Manufacturing Practice (GMP) standards, and manufacturers must comply with labeling, pharmacovigilance, and post-marketing surveillance requirements. Regulatory oversight also governs product claims, ingredient concentrations, and manufacturing consistency. Although regulatory compliance increases development timelines and costs, it supports product quality and strengthens confidence among healthcare professionals and consumers.

The topical analgesics industry faces a high level of product substitution due to the availability of multiple pain management alternatives. Patients frequently use oral NSAIDs, acetaminophen, opioids, corticosteroid injections, physical therapy, and complementary therapies depending on pain severity and clinical indication. Non-pharmacological approaches such as heat therapy, cold therapy, exercise programs, and rehabilitation services also compete with topical products. Within the topical segment itself, numerous creams, gels, sprays, patches, ointments, and counterirritant products containing different active ingredients provide additional substitution options. The wide availability of generic products further increases competition across both prescription and OTC categories.

Geographical expansion remains moderate to high as pharmaceutical companies continue to strengthen their presence across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Growth is supported by increasing awareness of localized pain management, expanding retail pharmacy networks, wider e-commerce availability, and improving healthcare access in emerging economies. Companies are introducing approved products into additional countries through regional partnerships, licensing agreements, and expanded distribution channels. Rising prevalence of musculoskeletal disorders, aging populations, and increasing demand for self-managed pain relief continue to support expansion opportunities. Local manufacturers are also broadening product availability by introducing cost-effective generic topical analgesics across developing healthcare markets.

Global Topical Analgesics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global topical analgesics market report based on drug class, pain, dosage form, distribution channel, prescription and region:

  • Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Counterirritants
  • Capsaicin-Based Analgesics
  • Combination Topical Analgesics
  • Pain Outlook (Revenue, USD Billion, 2021 - 2033)
  • Nociceptive Pain
  • Neuropathic Pain
  • Mixed Pain
  • Dosage Form Outlook (Revenue, USD Billion, 2021 - 2033)
  • Creams
  • Gels
  • Ointments
  • Patches
  • Sprays
  • Others
  • Prescription Outlook (Revenue, USD Billion, 2021 - 2033)
  • Over the Counter (OTC)
  • Prescription (Rx)
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Supermarkets & Hypermarkets
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Pain
    • 1.2.3. Dosage Form
    • 1.2.4. Prescription
    • 1.2.5. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Topical Analgesics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Topical Analgesics Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2025 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
  • 4.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • 4.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, 2021 - 2033 (USD Billion)
  • 4.5. Local Anesthetics
    • 4.5.1. Local Anesthetics Market, 2021 - 2033 (USD Billion)
  • 4.6. Counterirritants
    • 4.6.1. Counterirritants Market, 2021 - 2033 (USD Billion)
  • 4.7. Capsaicin-Based Analgesics
    • 4.7.1. Capsaicin-Based Analgesics Market, 2021 - 2033 (USD Billion)
  • 4.8. Combination Topical Analgesics
    • 4.8.1. Combination Topical Analgesics Market, 2021 - 2033 (USD Billion)

Chapter 5. Topical Analgesics Market: Pain Business Analysis

  • 5.1. Pain Market Share, 2025 & 2033
  • 5.2. Pain Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Pain, 2021 to 2033 (USD Billion)
  • 5.4. Nociceptive Pain
    • 5.4.1. Nociceptive Pain Market, 2021 - 2033 (USD Billion)
  • 5.5. Neuropathic Pain
    • 5.5.1. Neuropathic Pain Market, 2021 - 2033 (USD Billion)
  • 5.6. Mixed Pain
    • 5.6.1. Mixed Pain Market, 2021 - 2033 (USD Billion)

Chapter 6. Topical Analgesics Market: Dosage Form Business Analysis

  • 6.1. Dosage Form Market Share, 2025 & 2033
  • 6.2. Dosage Form Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2021 to 2033 (USD Billion)
  • 6.4. Creams
    • 6.4.1. Creams Market, 2021 - 2033 (USD Billion)
  • 6.5. Gels
    • 6.5.1. Gels Market, 2021 - 2033 (USD Billion)
  • 6.6. Ointments
    • 6.6.1. Ointments Market, 2021 - 2033 (USD Billion)
  • 6.7. Patches
    • 6.7.1. Patches Market, 2021 - 2033 (USD Billion)
  • 6.8. Sprays
    • 6.8.1. Sprays Market, 2021 - 2033 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 7. Topical Analgesics Market: Prescription Business Analysis

  • 7.1. Dosage Form Market Share, 2025 & 2033
  • 7.2. Dosage Form Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2021 to 2033 (USD Billion)
    • 7.3.1. Over the Counter (OTC)
    • 7.3.2. Over the Counter (OTC) Market, 2021 -2033 (USD Billion)
  • 7.4. Prescription (Rx)
    • 7.4.1. Prescription (Rx) Market, 2021 - 2033 (USD Billion)

Chapter 8. Topical Analgesics Market: Distribution Channel Business Analysis

  • 8.1. Dosage Form Market Share, 2025 & 2033
  • 8.2. Dosage Form Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2021 to 2033 (USD Billion)
  • 8.4. Hospital Pharmacies
    • 8.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • 8.5. Retail Pharmacies
    • 8.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • 8.6. Online Pharmacies
    • 8.6.1. Online Pharmacies Market, 2021 - 2033 (USD Billion)
  • 8.7. Supermarkets & Hypermarkets
    • 8.7.1. Supermarkets & Hypermarkets Market, 2021 - 2033 (USD Billion)

Chapter 9. Topical Analgesics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2025 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 9.4. North America
    • 9.4.1. North America Topical Analgesics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Reimbursement Framework
      • 9.4.2.5. U.S. Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Reimbursement Framework
      • 9.4.3.5. Canada Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. Reimbursement Framework
      • 9.4.4.5. Mexico Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 9.5. Europe
    • 9.5.1. Europe Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Reimbursement Framework
      • 9.5.2.5. UK Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Reimbursement Framework
      • 9.5.3.5. Germany Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. Reimbursement Framework
      • 9.5.4.5. France Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Reimbursement Framework
      • 9.5.5.5. Italy Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Reimbursement Framework
      • 9.5.6.5. Spain Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Reimbursement Framework
      • 9.5.7.5. Denmark Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Target Disease Prevalence
      • 9.5.8.3. Regulatory Framework
      • 9.5.8.4. Reimbursement Framework
      • 9.5.8.5. Sweden Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Target Disease Prevalence
      • 9.5.9.3. Regulatory Framework
      • 9.5.9.4. Reimbursement Framework
      • 9.5.9.5. Norway Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Reimbursement Framework
      • 9.6.2.5. Japan Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Reimbursement Framework
      • 9.6.3.5. China Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Reimbursement Framework
      • 9.6.4.5. India Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Reimbursement Framework
      • 9.6.5.5. Australia Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Target Disease Prevalence
      • 9.6.6.3. Regulatory Framework
      • 9.6.6.4. Reimbursement Framework
      • 9.6.6.5. South Korea Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Target Disease Prevalence
      • 9.6.7.3. Regulatory Framework
      • 9.6.7.4. Reimbursement Framework
      • 9.6.7.5. Thailand Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 9.7. Latin America
    • 9.7.1. Latin America Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. Reimbursement Framework
      • 9.7.2.5. Brazil Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Reimbursement Framework
      • 9.7.3.5. Argentina Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 9.8. Middle East and Africa
    • 9.8.1. Middle East and Africa Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Target Disease Prevalence
      • 9.8.2.3. Regulatory Framework
      • 9.8.2.4. Reimbursement Framework
      • 9.8.2.5. South Africa Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Target Disease Prevalence
      • 9.8.3.3. Regulatory Framework
      • 9.8.3.4. Reimbursement Framework
      • 9.8.3.5. Saudi Arabia Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Target Disease Prevalence
      • 9.8.4.3. Regulatory Framework
      • 9.8.4.4. Reimbursement Framework
      • 9.8.4.5. UAE Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Target Disease Prevalence
      • 9.8.5.3. Regulatory Framework
      • 9.8.5.4. Reimbursement Framework
      • 9.8.5.5. Kuwait Topical Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Haleon plc
      • 10.5.1.1. Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. Hisamitsu Pharmaceutical Co., Inc.
      • 10.5.2.1. Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. Kenvue Inc.
      • 10.5.3.1. Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Sanofi S.A.
      • 10.5.4.1. Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. Viatris Inc.
      • 10.5.5.1. Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Teikoku Pharma USA, Inc.
      • 10.5.6.1. Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. Perrigo Company plc
      • 10.5.7.1. Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Reckitt Benckiser Group plc.
      • 10.5.8.1. Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. Advantice Health, LLC.
      • 10.5.9.1. Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Strategic Initiatives
    • 10.5.10. Sun Pharmaceutical Industries Ltd.
      • 10.5.10.1. Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Topical Analgesics Market, by region, 2021 - 2033 (USD Billion)
  • Table 4. Global Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 5. Global Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 6. Global Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 7. Global Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 8. Global Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 9. North America Topical Analgesics Market, by country, 2021 - 2033 (USD Billion)
  • Table 10. North America Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 11. North America Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 12. North America Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 13. North America Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 14. North America Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 15. U.S.Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 16. U.S.Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 17. U.S. Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 18. U.S. Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 19. U.S. Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 20. Canada Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 21. Canada Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 22. Canada Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 23. Canada Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 24. Canada Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 25. Mexico Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 26. Mexico Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 27. Mexico Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 28. Mexico Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 29. Mexico Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 30. Europe Topical Analgesics Market, by country, 2021 - 2033 (USD Billion)
  • Table 31. Europe Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 32. Europe Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 33. Europe Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 34. Europe Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 35. Europe Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 36. UK Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 37. UK Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 38. UK Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 39. UK Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 40. UK Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 41. Germany Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 42. Germany Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 43. Germany Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 44. Germany Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 45. Germany Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 46. France Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 47. France Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 48. France Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 49. France Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 50. France Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 51. Italy Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 52. Italy Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 53. Italy Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 54. Italy Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 55. Italy Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 56. Spain Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 57. Spain Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 58. Spain Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 59. Spain Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 60. Spain Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 61. Norway Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 62. Norway Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 63. Norway Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 64. Norway Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 65. Norway Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 66. Denmark Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 67. Denmark Topical Analgesics Market, by pain ,2021 - 2033 (USD Billion)
  • Table 68. Denmark Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 69. Denmark Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 70. Denmark Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 71. Sweden Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 72. Sweden Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 73. Sweden Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 74. Sweden Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 75. Sweden Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 76. Asia Pacific Topical Analgesics Market, by country, 2021 - 2033 (USD Billion)
  • Table 77. Asia Pacific Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 78. Asia Pacific Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 79. Asia Pacific Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 80. Asia Pacific Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 81. Asia Pacific Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 82. Japan Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 83. Japan Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 84. Japan Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 85. Japan Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 86. Japan Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 87. China Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 88. China Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 89. China Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 90. China Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 91. China Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 92. India Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 93. India Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 94. India Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 95. India Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 96. India Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 97. Australia Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 98. Australia Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 99. Australia Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 100. Australia Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 101. Australia Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 102. South Korea Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 103. South Korea Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 104. South Korea Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 105. South Korea Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 106. South Korea Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 107. Thailand Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 108. Thailand Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 109. Thailand Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 110. Thailand Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 111. Thailand Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 112. Latin America Topical Analgesics Market, by country, 2021 - 2033 (USD Billion)
  • Table 113. Latin America Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 114. Latin America Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 115. Latin America Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 116. Latin America Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 117. Latin America Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 118. Brazil Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 119. Brazil Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 120. Brazil Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 121. Brazil Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 122. Brazil Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 123. Argentina Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 124. Argentina Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 125. Argentina Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 126. Argentina Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 127. Argentina Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 128. Middle East & Africa Topical Analgesics Market, by country, 2021 - 2033 (USD Billion)
  • Table 129. Middle East & Africa Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 130. Middle East & Africa Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 131. Middle East & Africa Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 132. Middle East & Africa Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 133. Middle East & Africa Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 134. South Africa Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 135. South Africa Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 136. South Africa Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 137. South Africa Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 138. South Africa Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 139. Saudi Arabia Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 140. Saudi Arabia Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 141. Saudi Arabia Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 142. Saudi Arabia Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 143. Saudi Arabia Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 144. UAE Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 145. UAE Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 146. UAE Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 147. UAE Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 148. UAE Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 149. Kuwait Topical Analgesics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 150. Kuwait Topical Analgesics Market, by pain, 2021 - 2033 (USD Billion)
  • Table 151. Kuwait Topical Analgesics Market, by dosage form, 2021 - 2033 (USD Billion)
  • Table 152. Kuwait Topical Analgesics Market, by prescription type, 2021 - 2033 (USD Billion)
  • Table 153. Kuwait Topical Analgesics Market, by distribution channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Topical Analgesics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Topical Analgesics Market dynamics
  • Fig. 11 Topical Analgesics Market: Porter's five forces analysis
  • Fig. 12 Topical Analgesics Market: PESTLE analysis
  • Fig. 13 Drug Class market, 2021 - 2033 (USD Billion)
  • Fig. 14 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, 2021 - 2033 (USD Billion)
  • Fig. 15 Local Anesthetics Market, 2021 - 2033 (USD Billion)
  • Fig. 16 Counterirritants Market, 2021 - 2033 (USD Billion)
  • Fig. 17 Capsaicin-Based Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 18 Combination Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 19 Pain Market, 2021 - 2033 (USD Billion)
  • Fig. 20 Nociceptive Pain Market, 2021 - 2033 (USD Billion)
  • Fig. 21 Neuropathic Pain Market, 2021 - 2033 (USD Billion)
  • Fig. 22 Mixed Pain Market, 2021 - 2033 (USD Billion)
  • Fig. 23 Dosage Form Market, 2021 - 2033 (USD Billion)
  • Fig. 24 Creams Market, 2021 - 2033 (USD Billion)
  • Fig. 25 Gels Market, 2021 - 2033 (USD Billion)
  • Fig. 26 Ointments Market, 2021 - 2033 (USD Billion)
  • Fig. 27 Patches Market, 2021 - 2033 (USD Billion)
  • Fig. 28 Sprays Market, 2021 - 2033 (USD Billion)
  • Fig. 29 Others Market, 2021 - 2033 (USD Billion)
  • Fig. 30 Prescription Market, 2021 - 2033 (USD Billion)
  • Fig. 31 Over the Counter (OTC) Market, 2021 - 2033 (USD Billion)
  • Fig. 32 Prescription (Rx) Market, 2021 - 2033 (USD Billion)
  • Fig. 33 Distribution Channel Market, 2021 - 2033 (USD Billion)
  • Fig. 34 Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • Fig. 35 Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • Fig. 36 Online Pharmacies Market, 2021 - 2033 (USD Billion)
  • Fig. 37 Supermarkets & Hypermarkets Market, 2021 - 2033 (USD Billion)
  • Fig. 38 Regional Marketplace: Key takeaways
  • Fig. 39 North America Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 40 U.S. country dynamics
  • Fig. 41 U.S. Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 42 Canada country dynamics
  • Fig. 43 Canada Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 44 Mexico country dynamics
  • Fig. 45 Mexico Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 46 Europe Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 47 UK country dynamics
  • Fig. 48 UK Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 49 Germany country dynamics
  • Fig. 50 Germany Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 51 France country dynamics
  • Fig. 52 France Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 53 Italy country dynamics
  • Fig. 54 Italy Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 55 Spain country dynamics
  • Fig. 56 Spain Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 57 Norway country dynamics
  • Fig. 58 Norway Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 59 Sweden country dynamics
  • Fig. 60 Sweden Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 61 Denmark country dynamics
  • Fig. 62 Denmark Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 63 Asia Pacific Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 64 Japan country dynamics
  • Fig. 65 Japan Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 66 China country dynamics
  • Fig. 67 China Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 68 India country dynamics
  • Fig. 69 India Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 70 Australia country dynamics
  • Fig. 71 Australia Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 72 South Korea country dynamics
  • Fig. 73 South Korea Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 74 Thailand country dynamics
  • Fig. 75 Thailand Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 76 Latin America Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 77 Brazil country dynamics
  • Fig. 78 Brazil Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 79 Argentina country dynamics
  • Fig. 80 Argentina Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 81 MEA Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 82 South Africa country dynamics
  • Fig. 83 South Africa Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 84 Saudi Arabia country dynamics
  • Fig. 85 Saudi Arabia Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 86 UAE country dynamics
  • Fig. 87 UAE Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 88 Kuwait country dynamics
  • Fig. 89 Kuwait Topical Analgesics Market, 2021 - 2033 (USD Billion)
  • Fig. 90 Company categorization
  • Fig. 91 Company Market position analysis
  • Fig. 92 Strategic framework